Drug >>Departmental Directives >>Manufacturing
 
  • SFDA: Notification on the Decision of 7 Injections such as Houttuynia Cordata Injection  (Directive; Document No: GuoShiYaoJianBan[2006]461; Promulgation Date: 2006-09-05)
  • SFDA: Notification on First List of Community and Rural Essential Drugs to be produced by Designated Enterprises  (Directive; Document No: GuoShiYaoJianShi[2006]343; Promulgation Date: 2006-06-23)
  • SFDA: Notification on Issues Related to Prohibiting Chlorofluorocarbon (CFC) from Being Used as Drug Aerosol Excipients  (Directive; Document No: GuoShiYaoJianZhu[2006]279; Promulgation Date: 2006-06-22)
  • SFDA: Notification on Printing and Distributing “Plan for Implementing Inspections on Special Items of National Drug Production”  (Directive; Document No: GuoShiYaoJianAn[2006]299; Promulgation Date: 2006-06-28)
  • SFDA: Notification on Printing and Distributing “Good Manufacturing Practices for Drug Excipients”  (Directive; Promulgated by State Food and Drug Administration; Promulgation Date: 2006-03-28)
  • SFDA: Views on Intellectual Property Issues related to Mannatide  (Directive; Document No: GuoShiYaoJianZhu[2006]252; Promulgation Date: 2006-06-13)
  • SFDA: Notification on Further Strengthening Supervision and Administration of Drug Manufacturers  (Directive; Document No: ShiYaoJianDian[2006]8; Promulgation Date: 2006-05-18)
  • SFDA: Notification on Printing and Distributing Interim Provisions on Drug GMP Flight Inspection  (Directive; Document No: GuoShiYaoJianAn[2006]165; Promulgation Date: 2006-04-24)
  • SFDA: Notification on Management of the Use of Leopard Bones  (Directives; Document No: GuoShiYaoJianZhu[2006]118; Promulgation Date: 2006-03-21)
  • SFDA: Notification on Printing and Distributing “Requirements for Record Keeping of Pharmaceutical Processing Entrusted by Overseas Drug Manufacturers”  (Directive; Document No: GuoShiYaoJianAn[2005]541; Promulgation Date: 2005-11-15)
  • SFDA: Notification on Printing and Distributing “Administration Provisions for the Certification of Good Manufacture Practice”  (Directive; Document No.: GuoShiYaoJianAn[2005]437; Promulgation Date: 2005-09-07)
  • SFDA: Notifications on Implementing Key Supervision and Administration on Manufacturers of Controlled Substances and Blood Products  (Directive; Document No: GuoShiYaoJianAn[2005]288; Promulgation Date: 2005-06-16)
  • SFDA: Notification on Promulgating “Standards for Registration Application Data of Domestic Class Ⅲ and Overseas Medical Devices”  (Directive; Document No: GuoShiYaoJianXie[2005]111; Promulgation Date: 2005-3-22)
  • SFDA:Notification on Using Problem of Natural Musk, Bear Gall Powder and So on  (Directive; Document No: GuoShiYaoJianZhu[2005]110; Promulgation Date: 2005-3-21)
  • SFDA: Notification on Promulgating Principal Guidance for the Quality Control of Positron Radiopharmaceuticals  (Directive; Document No: ShiYaoJianAn[2004]324; Promulgation Date: 2004-07-05)
  • SFDA: Supplementary Notification on Relevant Issues Concerning the Manufacture of Licorice Oral Solution Compound  (Directive; Document No: GuoShiYaoJianAn[2004]323; Promulgation Date: 2004-07-05)
  • SFDA: Notification on Relevant Issues Concerning the Manufacture of Licorice Oral Solution Compound  (Directive; Document No: GuoShiYaoJianAn[2004]186; Promulgation Date: 2004-05-25)
  • SDA: Notification on Issues Concerning Changing the Registration Address of Drug Manufacture License  (Directive;Document No: YaoJianAnHan[2002]128; Promulgation Date: 2002-07-31)
  • SFDA: Notification on Issues Concerning Examining and Approving Changes of Name and Address of Pharmaceutical Manufacture Enterprises  (Directive; Document No: ShiYaoJianZhuHan[2003]74; Promulgation Date: 2003-08-25)
  • SFDA: Circular of Reply on Issues Concerning Product Variety Attribution after Manufacture Plants Transfer to Independent Drug Manufacturers  (Directive; Document No: ShiYaoJianAnHan[2003]56; Promulgation Date: 2003-07-14)
  • 1 2 > Total:39